Masimo (MASI) Financial Analysis & Valuation | Quarter Chart
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the p... more
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospi... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $9.42B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Catherine Szyman |
| IPO Date | 2007-08-08 | CAGR | 27.49% |
| Employees | 7,500 | Website | www.masimo.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 2.12% | Total Yield | 2.12% |
MASI chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $9.75B | P/E | 44.43 | Forward P/E | — | PEG | — |
| P/S | 10.76 | P/B | 21.29 | P/CF | 72.39 | P/FCF | 80.68 |
| Sales | $1.56B | Sales 1Y | -14.42% | Sales 3Y | -32.14% | Sales 5Y | 32.85% |
| EPS | $4.05 | EPS 1Y | — | EPS 3Y | -32.72% | EPS 5Y | -62.94% |
| Sales QoQ | -2.16% | EPS QoQ | -14.17% | Sales QoQ Avg | 2.19% | EPS QoQ Avg | -152.15% |
| Gross Margin | 61.73% | Operating Margin | 19.85% | Profit Margin | 4.9% | ROCE | 23.49% |
| ROA | 5% | ROE | 9% | Altman Z Score | 9.77 | Piotroski Score | 8 |
| Current Ratio | 2.68 | Quick Ratio | 1.45 | Cash Ratio | 0.38 | Op. CF Ratio | 0.14 |
| Debt/Equity | 0.62 | Debt/Assets | 0.3 | Lt Debt/Equity | 0.6 | Lt Debt/Cap. | 0.36 |
| Intrst Cov. | 10.11 | Inventory Turnover | 1.49 | Asset Turnover | 0.95 | Receivables Turnover | 5.39 |
| Enterprise Value | $9.75B | P/E Ratio | 44.43 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 10.76 | P/B Ratio | 21.29 |
| P/CF Ratio | 72.39 | P/FCF Ratio | 80.68 |
| EPS | $4.05 | EPS Growth 1Y | — |
| EPS Growth 3Y | -32.72% | EPS Growth 5Y | -62.94% |
| Revenue Growth 1Y | -14.42% | Gross Margin | 61.73% |
| Operating Margin | 19.85% | Profit Margin | 4.9% |
| ROE | 9% | ROA | 5% |
| ROCE | 23.49% | Current Ratio | 2.68 |
| Quick Ratio | 1.45 | Cash Ratio | 0.38 |
| Debt/Equity | 0.62 | Interest Coverage | 10.11 |
| Altman Z Score | 9.77 | Piotroski Score | 8 |
Masimo (MASI) valuation & financials
Masimo (MASI) has a market capitalization of $9.42B and trades at a price-to-earnings ratio of 44.4. It operates in the Healthcare sector (Medical - Devices).
Masimo's revenue grew -14.4% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)